key: cord-0882960-ptq8hpk1
authors: Bellanger, Anne-Pauline; Navellou, Jean-Christophe; Lepiller, Quentin; Brion, Annie; Brunel, Anne-Sophie; Millon, Laurence; Berceanu, Ana
title: Mixed mold infection with Aspergillus fumigatus and Rhizopus microsporus in a Severe Acute Respiratory syndrome Coronavirus 2 (SARS-CoV-2) patient
date: 2021-01-27
journal: Infect Dis Now
DOI: 10.1016/j.idnow.2021.01.010
sha: 09d78bec285134948c966535eeb03661a559fc56
doc_id: 882960
cord_uid: ptq8hpk1

nan

In the recent context of the Coronavirus Disease 2019 (COVID-19) pandemic, secondary fungal infections such as invasive pulmonary aspergillosis have been reported for about 30% of the cases admitted to the ICU, mostly in patients in whom the European Organization for the Research and Treatment of Cancer: Mycoses Study Group Education and Research Consortium (EORTC/MSGERC) host factors were absent [1] [2] [3] . At the University Hospital of Besancon (northeastern France), while a similar proportion of putative invasive pulmonary aspergillosis was observed, we also had one case of mixed-mold infection displaying both Aspergillus fumigatus and Rhizopus microsporus isolated in the respiratory samples of an immunocompromised patient with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We propose here to report and discuss this rare occurrence.

A 55-year-old man was diagnosed in 2017 with follicular lymphoma, which recurred in 2018.

After autologous hematopoietic stem cell transplantation (auto-HCT) was planned, the patient tested positive for Influenza B virus (Day -20). Prior to auto-HCT, a SARS-CoV-2 Realtime Polymerase Chain Reaction (RT-PCR) test [4] was performed from a nasopharyngeal sample on Day -7 and was negative. Auto-HCT was performed on Day 0 (D0). Over the following days, the patient became feverish while in aplasia despite antibiotic treatment, In the present case, the patient displayed the EORCT/MSGERC host factors [3] and nonspecific radiology signs of IMD. He had two positive cultures and two positive A. fumigatus qPCR in BALF (Figure 1 ), which meant that the criteria required to confirm the existence of a putative IPA, as defined by White et al., had been fulfilled [7] .

The originality of this IMD case consisted in the association of A. fumigatus with a Mucorales species. Several cases of mucormycosis in SARS-CoV-2-infected patients have been reported recently, describing varied clinical forms in those without EORCT/MSGERC host factors [8] .

The hypothesis put forward to explain these rare occurrences were 1) that the steroids used to treat the SARS-CoV-2 infection may favor the development of molds, providing that the latter were pre-existing and/or colonizing the patient and 2) that the SARS-CoV-2 infection itself may induce an immunosuppressive state exposing the patient to IMD [8] .

In the present case, from Day 6 to Day 34 the SARS-CoV-2 viral load in respiratory samples remained high, with a Ct value < Ct 25 [9] [10] , and it was associated with pronounced J o u r n a l P r e -p r o o f 6 elevation of inflammatory markers. The slow-decline of SARS-CoV-2 viral load could reflect failed triggering of an effective innate immune response against the virus. A recent study showed that a hematologic malignancy was independently associated with high SARS-CoV-2 viral load (Ct <25) upon admission [9] ; moreover, high SARS-CoV-2 viral load (Ct <25) has been shown to be independently associated with an outcome of death [9] [10] .

This patient had two major risk factors: SARS-CoV-2 infection and severe immunosuppression. Even though it was not possible, in our case, to determine which of the two was more damaging, it may have provided some insight into the interactions between molds, such as A. fumigatus and Mucorales, and the SARS-CoV2 infected lung [2] .

This reported case of secondary fungal infection in an immunocompromised SARS-CoV-2 infected patient is a rare occurrence due to the mixed presence of A. fumigatus and a Mucorales species.

COVID-19 Associated Pulmonary Aspergillosis

Diagnosing COVID-19-associated pulmonary aspergillosis

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the

European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

SARS-CoV-2 respiratory viral loads and association with clinical and biological features

Combining Aspergillus mitochondrial and ribosomal QPCR, in addition to galactomannan assay, for early diagnosis of invasive aspergillosis in hematology patients

Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF)

A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU

A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis

Is Higher Viral Load in SARS-CoV-2 Associated with Death?

Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19